Discover
ENLV
Enlivex Ltd.
0.54
2 x 0.40
2 x 0.69
bid
ask
-
0.01
1.51%
2 @ 04:53 AM
0.54 +0.00 (0.00%)
| Ytd | -22.96% | |
| 1y | -51.64% |
0.52
day range
0.59
0.52
52 week range
2.10
| Open | 0.59 | Prev Close | 0.55 | Low | 0.52 | High | 0.59 | Mkt Cap | 130.55M |
| Vol | 684.89K | Avg Vol | 433.07K | EPS | 25.48 | P/E | 0.02 | Forward P/E | -2.14 |
| Beta | 1.10 | Short Ratio | 0.56 | Inst. Own | 18.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-30 | 50-d Avg | 0.74 | 200-d Avg | 0.94 | 1yr Est | 9.50 |
ENLV News
benzinga.com
Enlivex Holds 79.569B RAIN Token With Total Value Of ~$1.14B
Enlivex Ltd. (NASDAQ:ENLV, "Enlivex" or the "Company")), a quality longevity company
benzinga.com
Enlivex Receives Australian Patent Entitled 'Therapeutic Apoptotic Cells For Treatment Of Osteoarthr
The patent will provide Enlivex with added intellectual property protection in Australia through at
benzinga.com
Enlivex To Feature Extended 3-Month And 6-Months Clinical Data In Knee Osteoarthritis Phase Iia Tria
The data were selected for an oral podium presentation at EULAR and will be presented by Prof. Phili